Related Experiment Video
Updated: May 3, 2026

Modified Octopus Technique for Thoracoabdominal Aortic Aneurysm
Published on: August 1, 2025
Elective stent-graft treatment for the management of thoracic aorta mural thrombus
Insights
Stent-graft treatment is effective for thoracic aorta mural thrombus (AMT), especially for mobile thrombi. Evaluating thrombus mobility aids in selecting patients for intervention, improving outcomes.
Area of Science:
- Cardiovascular Surgery
- Vascular Medicine
- Interventional Radiology
Background:
- Management of aorta mural thrombus (AMT) in the thoracic aorta remains controversial.
- Identifying optimal treatment strategies and patient selection criteria for AMT is crucial.
Purpose of the Study:
- To describe the management of thoracic AMT using conservative or stent-graft approaches.
- To analyze morphological thrombus characteristics for guiding intervention selection.
Main Methods:
- Retrospective review of 13 patients with thoracic AMT (2006-2013).
- Comparison of clinical data, treatments (conservative vs. stent-graft), and outcomes.
- Analysis of thrombus morphology (size, aspect, mobility) in relation to treatment and outcomes.
Main Results:
- 13 patients (9 male, mean age 53) treated for symptomatic (n=8) or asymptomatic (n=5) AMT.
- Stent-graft used in 7 patients, thrombectomy in 1, anticoagulation alone in 5.
- High thrombus mobility was significantly associated with adverse outcomes (p=.048).
- Endovascular exclusion of AMT was successful with no 30-day complications or deaths and no midterm recurrence.
Conclusions:
- Stent-graft exclusion of AMT is an effective treatment approach.
- Systematic evaluation of thrombus mobility via real-time imaging aids in defining indications for radical treatment.
Background:
Optimal management of aorta mural thrombus (AMT) continues to be controversial. The aim of this study was to describe the management of AMT in the thoracic aorta with either conservative or stent-graft treatment and to analyze the role of morphological characteristics of thrombus in the selection of suitable candidates for intervention.
Methods:
A retrospective review was conducted of all patients admitted for thoracic AMT. Clinical data, treatment used, and outcomes were recorded. Patients were divided in two groups according to the treatment used: either conservative or stent-graft. Morphological features of thrombus, including size, sessile or pedunculated aspect and mobility, were compared between the two groups.
Results:
From January 2006 to March 2013, 13 consecutive patients (nine male, mean age 53, range 37-76) were admitted for symptomatic (n = 8) or asymptomatic AMT (n = 5). All patients received unfractionated heparin. Management of primary aortic thrombus required stent-graft in seven patients, aortic thrombectomy in one, and anticoagulation therapy alone in five. Indications for intervention were recurrent embolism (n = 4), occurrence of embolism under heparin (n = 1), or persistent thrombus (n = 2). Endovascular exclusion of AMT was successful in all cases, with no complications or deaths at 30 days and no recurrence at midterm. Analysis of the morphological features of the thrombus identified solely the high degree mobility as associated with adverse outcome (p = .048).
Conclusion:
In our experience, stent-graft exclusion of AMT is an effective approach. Systematic evaluation of thrombus mobility by a real-time imaging study can be helpful to better define the indications for radical treatment of the aortic lesion.
Related Concept Videos
Aneurysm III: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Aortic Regurgitation III: Medical Management
Mitral Stenosis III: Medical Management

